PIMCO Active Bond Exchange-Traded Fund
Loading news...
The PIMCO Active Bond ETF (BOND) uses an active, multi-sector fixed-income approach for yield enhancement and capital appreciation. BOND has underperformed its benchmark proxy, AGG ETF, in price return but outperformed in total return due to its consistent monthly distributions. The ETF's portfolio exposure is dynamic, with management adjusting allocations based on market outlook.
PIMCO Active Bond ETF (BOND) continues to deliver strong returns in 2025, outperforming typical intermediate duration fixed income vehicles. BOND benefits from a favorable macro environment, with investment grade bonds, Agency MBS, and Treasuries driving robust performance. We maintain a bullish outlook on BOND through 2026, citing its resilience and attractive risk-adjusted return profile.
Bought 87,752 shares, with an estimated transaction value of $8.10 million based on the average price for the quarter Change equals 1.49% of the fund's reportable assets under management (AUM) Post-trade position: 187,980 shares valued at $17.55 million The stake represents 3.22% of the fund's AUM, placing it outside the fund's top five holdings
Visualizes functional protein-protein interactions directly within fixed tissue at subcellular resolution Enables simultaneous detection of protein proximity, RNA, and proteins on the same tissue section Automates spatial multiomic workflows with the BOND RX platform from Leica Biosystems MINNEAPOLIS , Oct. 28, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced the launch of the ProximityScope™ assay, a groundbreaking spatial solution developed for seamless integration with the BOND RX staining platform from Leica Biosystems. This powerful combination enables researchers to visualize functional protein-protein interactions on fixed tissue with subcellular resolution – bringing Leica's automation excellence from Leica Biosystems to the forefront of spatial biology.
BOND is an actively-managed investment-grade bond ETF managed by PIMCO. PIMCO Active Bond Exchange-Traded Fund ETF compares favorably to its benchmark, somewhat unfavorably to its peers, including IGEB. Good choice, but there are even better, cheaper bond ETFs out there.
NEW YORK--(BUSINESS WIRE)--BOND, the world's first premium fractional aviation company, today announced the close of $320 million in preferred equity and debt financing led by credit funds and accounts managed by leading global investment firm KKR, with $30 million of equity funding from a select group of founding partners. In a market where demand for private flying is at record highs and fractional ownership is outpacing every other category of business aviation, BOND introduces a model built.
PIMCO Active Bond ETF offers active, diversified fixed-income exposure with a focus on risk control and long-term income and capital appreciation. Current market conditions favor agency mortgage-backed securities (MBS), as their premium over investment-grade corporates is historically attractive, supporting an overweight in MBS. MBS have demonstrated defensive characteristics during equity market downturns, providing stability and income when most needed in a portfolio.
- Robust 24-month complete response (CR) rate of 41.8% observed for cretostimogene monotherapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are unresponsive to Bacillus Calmette Guerin (BCG) treatment -- 90% of 12-month responders remained disease free at 24 Months -- Safety profile remains consistent -
BOND has nearly doubled its AUM to $5.5 billion in the past two years and has outperformed its actively managed peers and passive benchmark. The fund primarily invests in investment-grade MBS bonds and Treasuries, with a portfolio duration of 6.5 years, placing it in the intermediate duration category. While BOND's annualized volatility of 7.4% is higher than the Bloomberg U.S. Aggregate Index's 5%, its superior total return performance suggests that the active management's risk-taking has been justified.
MEXICO CITY , June 12, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of Mexico's leading pharmaceutical and personal care companies with a growing international footprint, announced that on June 11, 2025, it completed the full early amortization of its debt certificates listed under the ticker symbol "LAB 23.
CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at AUA
VettaFi sat down with Jerome Schneider, PIMCO's Head of Short-Term Strategies, at Exchange. Schneider discussed the potential benefits of active management and PIMCO's priorities in the space.
PIMCO Active Bond Exchange-Traded Fund ETF is in focus as a volatile credit environment sets the scene for active bond management. BOND ETF's commentary suggests it remains committed to intermediate term treasuries, CLOs, and RMBS. Moreover, recent enterprise-wide commentary suggests that PIMCO is seeking EU exposure. We support intermediate-to-long-term U.S. treasury and CLO exposure. However, we highlight risks in RMBS and dislike the vehicle's disregard of investment grade corporate credit.
MINNEAPOLIS , April 2, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD), and Leica Biosystems, a global leader in anatomic pathology solutions. The expanded spatial multiomic collaboration now includes automation of ACD's new RNAscope™ Multiomic LS Assay and protease-free workflows on Leica's BOND RX research staining instrument, further advancing the capabilities of spatial biology research.
SCOTTSDALE, Ariz. , March 6, 2025 /PRNewswire/ -- Cyber Enviro-Tech, Inc. (OTCQB-CETI) is pleased to announce that its wholly-owned subsidiary, Cyber International of Turkey, following extensive due diligence, has been awarded a GBP $50 million Green Bond to capitalize its domestic and international environmental remediation projects.
NEW YORK , Dec. 20, 2024 /PRNewswire/ -- Neuberger Berman, a private, independent, employee-owned investment manager, is pleased to announce the launch of two new actively managed ETFs: Neuberger Berman Total Return Bond ETF (NYSE: NBTR) and Neuberger Berman Growth ETF (NYSE: NBGX). The new Neuberger Berman Total Return Bond ETF is a Core-plus fixed income portfolio seeking to outperform its benchmark over market cycles, driven by multiple potential alpha sources: Dynamic & Diverse Sector Allocations Utilize a broad opportunity set of fixed income sectors—not limited to benchmark sectors.
Bond market volatility has surged, with yields moving from near zero to multi-decade highs, creating a complex credit environment. PIMCO's actively managed BOND ETF offers a diversified portfolio with a focus on intermediate maturities, outperforming passive funds like BND over the past decade. Active management by PIMCO has consistently delivered superior returns, leveraging market insights and flexibility to navigate economic changes.
The Federal Reserve's recent rate cut and potential future cuts are expected to benefit bonds, real estate, and dividend stocks by lowering borrowing costs and increasing asset values. We revisit the four ETF portfolio, focusing on near-term rate cuts. The portfolio of these ETFs yields an average of 4.1% with a low expense ratio, positioning investors to capitalize on anticipated rate cuts.
BOND is a diversified bond ETF from PIMCO. It focuses on high-quality, investment-grade securities, mostly MBS. It sports an above-average 4.6% yield, and has slightly outperformed its benchmark since inception.